GC33905
CMI-392
Also known as 3-[[2-[2-(4-chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxy-1-methylurea
CMI-392 is a dual 5-lipoxygenese inhibitor and platelet-activating factor (PAF) receptor antagonist with IC50s of 100 and 10 nM, respectively
ChemicalCAS205654-37-1MW633.15FormulaC31H37ClN2O8S
- CAS number
- 205654-37-1
- Molecular weight
- 633.15
- Formula
- C31H37ClN2O8S
- Solubility
- Soluble in DMSO
- InChIKey
- LZVBMKDVEPGGFK-DQEYMECFSA-N
- Catalogue number
- GC33905
- Brand
- GLPBIO
Computed properties PubChem CID 6918268 · XLogP 4.9 · TPSA 133 Ų · H-bond donors 2
- XLogP
- 4.9
- TPSA
- 133 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 13
- Heavy atoms
- 43
SMILES CN(C(=O)NCC1=C(C(=CC(=C1)[C@@H]2CC[C@H](O2)C3=CC(=C(C(=C3)OC)OC)OC)OC)OCCSC4=CC=C(C=C4)Cl)O
Computed descriptors from PubChem (CID 6918268), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il